Oviya MedSafe’s new capabilities & credentials in Pharmacovigilance

Dear Colleagues,

 

Season’s greetings from Oviya MedSafe – your strategic partner for Pharmacovigilance!

I take great pleasure in e-meeting you through the May 2013 edition of Oviya MedSafe’s newsletter. I am glad to share with you about Oviya MedSafe’s advancements during the past month which have assured us that we are constantly progressing further in our journey towards excellence in providing global pharmacovigilance consulting and end-to-end managed medical affairs & drug safety services, to our clients.

 

To start with, I am immensely happy to announce that Oviya MedSafe now offers Pharmacovigilance Call Centre Services also. As an expansion of our medical information function, our call centre arrangement would help our clients by receiving inbound calls meant for consumers or healthcare professionals to report suspected adverse drug reactions and by performing outbound telephonic follow-ups with the reporters. We believe that this new strength will add a lot of value to our existing credentials of capable pharmacovigilance staff, state-of-the-art information technology facilities and safety database provisions.

 

Oviya MedSafe is proud to place on record that Mr Ganesan Ramakrishnan – our Drug Safety Manager, has been invited to share his experiences on the topic ‘Pharmacovigilance for Clinical Trials in India‘ at the 4th Annual Clinical Trials Summit 2013 organized by Virtue Insight, at the Kohinoor Continental Hotel, Mumbai on Friday, 20th June 2013. I take this opportunity to invite you and your colleagues to attend the event and provide Ganesan as well as me the chance to meet you for a detailed interaction on our services.

 

As you might already know, Oviya MedSafe’s event partnership with IQPC Singapore continues for the second consecutive year for the 4th Annual Pharmacovigilance Asia 2013 which is to be held between 18th and 21st June 2013. I take pleasure in inviting you to this conference on behalf of the organizers and firmly believe that it will provide a 360-degree perspective of the pharmacovigilance activities with respect to the Asian continent. Please do write to us for more information on this event.

 

As assured in the April 2013 edition of our newsletter, I now share the full-text PDF version of my article titled ‘Pharmacovigilance in India – A Perspective‘ which was published in the March 2013 edition of the magazine ‘Pharma Bio World’. Please click here to download and read it. I am keen to know your feedback on the article and look forward to further one-to-one discussions with you on its contents. I will share in the June 2013 edition of our newsletter my subsequent article titled ‘Pharmacovigilance Outsourcing and Career Advantages for Indian Professionals‘ which has been published in the April 2013 edition of the same magazine.

 

With the International Clinical Trials Day (commemorating 20th May, 1747 – the date on which James Lind, who is considered the originator of clinical trials, started his famous trial to treat scurvy) being around the corner, I, in my capacity as an Executive Committee Member of the Indian Society for Clinical Research (ISCR), request you to vibrantly celebrate this day within your organizations as a day of revelation. I share, with the permission of the Executive Committee, the official note released by ISCR to declare and explain the thoughts behind the ISCR Theme for International Clinical Trials Day 2013: Research Made The Difference. Click here to download, read & share it with your colleagues.

 

Before signing off for the month, I am pleased to let you know that ISCR will be collaborating with the Indian Medical Association – Tamil Nadu State Branch to organize a one-day workshop on Saturday, 29-June-2013 at Chennai on the topic ‘Fundamentals of Drug Development – For Medical Students & Practising Doctors‘ for improving awareness of clinical research as a science, among the non-investigator physicians and the young doctors in this part of the country. More information will be made available soon and you will also shortly hear from us on the agenda for the day along with the registration details. I request for your kind co-operation to make this workshop a grand success.